This trial is active, not recruiting.

Condition obstructive sleep apnea
Treatment cpap therapy
Sponsor University Hospital, Geneva
Start date August 2009
End date August 2009
Trial size 35 participants
Trial identifier NCT02061046, PRD 10-II-7


To study the impact of CPAP therapy on gait in patients with obstructive sleep apnea syndrome.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model case-only
Time perspective prospective
OSA patients assessed before and after 8 weeks of CPAP therapy
cpap therapy
8 weeks of CPAP therapy

Primary Outcomes

Gait parameters: gait velocity [m/s]
time frame: 8 weeks

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - OSA patients newly diagnosed Exclusion Criteria: - acute medical illness in the past months - neurological and psychiatric diseases - orthopaedic, rheumatologic or any sensory conditions affecting normal walking

Additional Information

Official title Impact of the CPAP on Gait in OSA Patients
Principal investigator Gilles Allali, MD/PhD
Description To study the impact of CPAP therapy on gait velocity and temproral gait in patients with obstructive sleep apnea syndrome using the SMTEC system. Patients will be assessed before and 8 weeks after CPAP therapy.
Trial information was received from ClinicalTrials.gov and was last updated in November 2015.
Information provided to ClinicalTrials.gov by University Hospital, Geneva.